SHOrt Course Radiation and TASOX (TAS102 Plus Oxaliplatin) Chemotherapy in Operable Rectal Cancer (SHORT)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04417699 |
|
Recruitment Status :
Completed
First Posted : June 5, 2020
Last Update Posted : March 25, 2024
|
Sponsor:
Providence Health & Services
Collaborator:
Taiho Oncology
Information provided by (Responsible Party):
Providence Health & Services
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | December 14, 2023 |
| Actual Study Completion Date : | February 21, 2024 |